Author

N Pagidipati

Institution: Duke Clinical Research Institute

Observed institution: Duke Clinical Research Institute

OpenAlex ID: A5159626109

Zilebesiran in combination with a diuretic in patients with uncontrolled hypertension: a subgroup analysis from the Phase 2 KARDIA-3 trial

2026 · N Pagidipati, M Weber, et al. · European Heart Journal · 1

Design and baseline data of AZURE-HeFH, a phase 3 study assessing the effect of the oral PCSK9 inhibitor laroprovstat on LDL cholesterol in patients with heterozygous familial hypercholesterolaemia

2026 · E S Stroes, R S Rosenson, et al. · European Heart Journal

Design and baseline data of AZURE-LDL, a phase 3 study assessing the effect of the oral PCSK9 inhibitor laroprovstat on LDL cholesterol in patients with, or at risk for, ASCVD

2026 · E S Stroes, M Koren, et al. · European Heart Journal

Works count: 3

Citation count: 1

H-index: 1

I10-index: